MLV & Co Sees Attractive Value From Sabra Health Care REIT By: Benzinga via Benzinga September 30, 2014 at 09:44 AM EDT In a report published Tuesday, MLV & Co analyst Paul Morgan reiterated a Buy rating and $31.00 price target on Sabra Health Care REIT ... Read More >> Related Stocks: Sabra REIT